BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Clovis Oncology Announces First Patient Enrolled In RUCAPANC Study

  June 16, 2014

   · 

  1 min read
• Pharm Country

  Instem Release: Clinical Research Center In Hungary Purchases ALPHADAS For New Phase I Unit

  June 16, 2014

   · 

  1 min read
• Policy

  Pathway Genomics Corporation Responds To Myriad Genetics, Inc. Lawsuit, Defends The Rights Of All Women To Receive BRCA Testing Regardless Of Socioeconomic Status

  June 16, 2014

   · 

  1 min read
• Biotech Beach

  Drug Information Association Release: Largest-Ever TMF Survey Reveals Lagging Technology Adoption And Manual Processes Significantly Impacting Clinical Trial Operations

  June 16, 2014

   · 

  1 min read
• BioCapital

  Bruker Corporation Announces Powerful New Mass Spectrometry Systems And Solutions For Life-Science Research, Clinical Research, Biopharma And Applied Markets

  June 16, 2014

   · 

  1 min read
• Business

  Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-Drug, Biomarker-Driven Clinical Trial For Lung Cancer

  June 16, 2014

   · 

  1 min read
• NOVACYT And Lab21 Announce Stock For Stock Completion

  June 16, 2014

   · 

  1 min read
• Drug Development

  Gilead Sciences, Inc. Announces Phase 3 Data Showing That The Fixed-Dose Combination Of Ledipasvir/Sofosbuvir Achieved 100 Percent Sustained Virologic Response (SVR12) Among Patients With Chronic Hepatitis C In Japan

  June 16, 2014

   · 

  1 min read
• Drug Development

  Celgene International Sárl Release: Retrospective Analysis Of Overall Survival Adjusting For Patient Crossover In Phase III Study Of POMALYST®/IMNOVID® (Pomalidomide) In Previously Treated Multiple Myeloma Presented At EHA

  June 16, 2014

   · 

  1 min read
• Drug Development

  Celgene International Sárl Release: Results From Phase III Study (AML-001) Of VIDAZA® (Azacitidine For Injection) In Acute Myeloid Leukemia Presented At European Hematology Association

  June 16, 2014

   · 

  1 min read